Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,489.83
(
-0.26%
)
News Focus
News Focus
Post# of 82595
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

johnnyfiber

Send PM Follow Ignore
Followers 11
Posts 3235
Boards Moderated 0
Alias Born 01/06/2007

johnnyfiber

Re: johnnyfiber post# 64080

Sunday, 06/03/2007 12:55:23 PM

Sunday, June 03, 2007 12:55:23 PM

Post# of 82595
I believe DnaPrints' technology is key for many companies. DnaPrints' Patents cover a wide spectrum in the Pharma Industry. It was stated as such by Gabriel. I believe Merck is playing catch-up with the M2Gen deal. This will most certainly give DnaPrint needed leverage in any restructuring, buy-out,etc... Of course a product to market will be the cherry on our Sh-t Sundae...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote